STRESSING the use of marijuana remains illegal for both recreational and medical use, the Dangerous Drugs Board (DDB) yesterday clarified that Cannabidiol could be allowed as alternative treatment.
The DDB said Cannabidiol, which is just one of the hundreds of cannabinoids found in marijuana, can be used to treat certain forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.
“CBD or cannabidiol is not cannabis per se, and it is by far the only component proved to have medical benefits,” the DDB said.
The United States Food and Drug Administration (US FDA) has allowed the use and registered the medicine called Epidiolex which is CBD with not more than 0.1 percent tetrahydrocannabidiol (THC), based on the approved threshold of the United States Drug Enforcement Agency (US DEA).
Epidiolex is in tablet form with a maximum dosage of 20 milligrams per day.
With this threshold in mind, the Board is considering the adoption of a regulation to allow the use of the medication.
The DDB has been in consultation with experts from the academe, professional medical associations, the Department of Health, Food and Drug Administration, and Philippine Drug Enforcement Agency to finalize the regulation.
Last month, a public hearing was conducted in line with the proposed regulation as part of the board’s functions to reclassify, add or remove any drug from the list of dangerous drugs so that legitimate medical needs are not prevented from being treated with adequate amounts of appropriate medications.